ArticleHaematologica2023

Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis.

Lorenza Falini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.